See more : OptiBiotix Health Plc (OPTI.L) Income Statement Analysis – Financial Results
Complete financial analysis of Samyang Holdings Corporation (000070.KS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Samyang Holdings Corporation, a leading company in the Conglomerates industry within the Industrials sector.
- Grid Battery Metals Inc. (EVKRF) Income Statement Analysis – Financial Results
- Fang Holdings Limited (SFUNY) Income Statement Analysis – Financial Results
- Roth CH Acquisition IV Co. (ROCGU) Income Statement Analysis – Financial Results
- Halozyme Therapeutics, Inc. (0J2O.L) Income Statement Analysis – Financial Results
- Hochschild Mining plc (HCHDY) Income Statement Analysis – Financial Results
Samyang Holdings Corporation (000070.KS)
About Samyang Holdings Corporation
Samyang Holdings Corporation, together its subsidiaries, engages in chemical, food, packaging, pharmaceutical, and other businesses in South Korea. It produces and sells value-added materials, terephthalic acid, polycarbonate (PC) resins, bisphenol-A, engineering plastics, PC and polybutylene terephtalate compounds, PET bottles, and long fiber reinforced thermoplastics. It offers health and wellness products, and starch sugar; and operates a salad & brunch concept restaurant under the Seven Springs name, as well as a bakery under the Café Seven Springs name. In addition, the company develops and sells anti-cancer drugs, such as Genexol and Nanoxel PM; NicoStop, a smoking cessation patch; and biodegradable sutures, including Trisorb and Monosorb, as well as exports its products to 80 countries. Further, it provides IT services comprising IT consulting on system management and integration, and e-business services, as well as solutions in ERP, e-HR, MES, and mobile services to the public, finance, and manufacturing sectors. Samyang Holdings Corporation was founded in 1924 and is based in Seoul, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,210.85B | 3,316.78B | 3,107.31B | 2,471.23B | 2,488.56B | 2,563.48B | 2,396.29B | 2,311.47B | 2,176.56B | 2,213.37B | 2,329.15B | 1,864.07B | 1,180.82B | 1,064.39B | 1,860.19B | 1,368.67B | 1,201.35B |
| Cost of Revenue | 2,685.57B | 2,773.47B | 2,378.28B | 1,951.12B | 2,025.13B | 2,081.37B | 1,974.92B | 1,859.91B | 1,770.09B | 1,864.28B | 2,025.95B | 1,624.81B | 1,024.82B | 915.54B | 1,568.05B | 1,172.74B | 982.12B |
| Gross Profit | 525.28B | 543.31B | 729.03B | 520.11B | 463.43B | 482.11B | 421.37B | 451.55B | 406.47B | 349.09B | 303.19B | 239.25B | 156.00B | 148.85B | 292.14B | 195.93B | 219.23B |
| Gross Profit Ratio | 16.36% | 16.38% | 23.46% | 21.05% | 18.62% | 18.81% | 17.58% | 19.54% | 18.67% | 15.77% | 13.02% | 12.83% | 13.21% | 13.98% | 15.71% | 14.32% | 18.25% |
| Research & Development | 25.48B | 25.62B | 49.66B | 38.86B | 51.77B | 30.12B | 25.03B | 23.89B | 26.28B | 24.30B | 25.90B | 21.15B | 14.04B | 11.98B | 16.33B | 9.96B | 10.43B |
| General & Administrative | 27.68B | 27.20B | 19.01B | 18.74B | 26.23B | 25.39B | 23.12B | 22.76B | 21.90B | 21.48B | 22.06B | 17.14B | 12.26B | 12.22B | 12.04B | 12.58B | 12.96B |
| Selling & Marketing | 199.64B | 188.15B | 170.29B | 154.46B | 158.08B | 152.76B | 149.68B | 136.03B | 130.96B | 126.23B | 136.28B | 91.22B | 43.16B | 39.96B | 109.19B | 82.20B | 73.42B |
| SG&A | 368.15B | 215.35B | 189.30B | 173.20B | 184.31B | 178.15B | 172.80B | 158.79B | 152.85B | 147.71B | 158.34B | 108.37B | 55.42B | 52.17B | 121.22B | 94.77B | 86.38B |
| Other Expenses | 0.00 | 170.02B | 138.37B | 137.72B | 147.98B | 5.30B | 2.70B | -1.41B | 26.62B | -104.54M | 9.26B | 80.58B | 41.41B | 5.87B | -329.44M | 4.69B | -12.87B |
| Operating Expenses | 393.62B | 410.99B | 377.33B | 349.77B | 384.05B | 343.65B | 322.55B | 310.54B | 299.75B | 285.31B | 300.72B | 219.37B | 110.88B | 106.24B | 211.83B | 168.76B | 166.14B |
| Cost & Expenses | 3,079.20B | 3,184.45B | 2,755.61B | 2,300.89B | 2,409.19B | 2,425.02B | 2,297.46B | 2,170.45B | 2,069.84B | 2,149.58B | 2,326.67B | 1,844.19B | 1,135.69B | 1,021.78B | 1,779.88B | 1,341.50B | 1,148.26B |
| Interest Income | 33.23B | 14.41B | 7.77B | 10.49B | 13.24B | 9.23B | 9.25B | 7.62B | 11.62B | 13.67B | 14.36B | 16.06B | 12.44B | 11.38B | 15.80B | 6.20B | 4.73B |
| Interest Expense | 47.40B | 33.77B | 26.61B | 28.87B | 30.97B | 24.41B | 24.43B | 24.20B | 21.84B | 15.41B | 17.18B | 14.25B | 9.57B | 9.70B | 17.07B | 8.89B | 7.86B |
| Depreciation & Amortization | 113.40B | 114.03B | 92.26B | 93.18B | 91.73B | 77.03B | 76.56B | 82.68B | 70.01B | 54.19B | 57.94B | 42.49B | 44.51B | 47.20B | 47.35B | 32.67B | 34.42B |
| EBITDA | 444.81B | 246.36B | 443.92B | 263.51B | 171.10B | 215.48B | 175.39B | 223.69B | 176.73B | 117.98B | 60.30B | 171.97B | 98.09B | 193.68B | 193.38B | -25.19B | 68.25B |
| EBITDA Ratio | 13.85% | 8.24% | 14.92% | 12.62% | 8.32% | 9.17% | 8.86% | 9.85% | 8.97% | 4.58% | 3.40% | 11.59% | 15.55% | 18.33% | 10.82% | -1.24% | 5.55% |
| Operating Income | 131.66B | 132.32B | 351.70B | 170.34B | 115.40B | 138.46B | 98.83B | 141.01B | 106.72B | 63.78B | 2.47B | 19.88B | 36.02B | 50.30B | 80.32B | 27.17B | 53.09B |
| Operating Income Ratio | 4.10% | 3.99% | 11.32% | 6.89% | 4.64% | 5.40% | 4.12% | 6.10% | 4.90% | 2.88% | 0.11% | 1.07% | 3.05% | 4.73% | 4.32% | 1.98% | 4.42% |
| Total Other Income/Expenses | 134.88B | -5.66B | -6.83B | 344.41M | -34.38B | -9.15B | -9.47B | -38.33B | -1.82B | -17.44B | -12.56B | 95.35B | 93.80B | 93.98B | 48.64B | -93.92B | -27.12B |
| Income Before Tax | 266.53B | 126.66B | 344.87B | 170.68B | 81.02B | 129.31B | 89.36B | 102.68B | 104.90B | 46.35B | -10.09B | 149.25B | 129.82B | 136.77B | 128.96B | -66.75B | 25.97B |
| Income Before Tax Ratio | 8.30% | 3.82% | 11.10% | 6.91% | 3.26% | 5.04% | 3.73% | 4.44% | 4.82% | 2.09% | -0.43% | 8.01% | 10.99% | 12.85% | 6.93% | -4.88% | 2.16% |
| Income Tax Expense | 39.52B | 20.81B | 70.79B | 27.42B | 18.98B | 26.80B | 22.17B | 37.54B | 26.89B | 25.34B | 16.12B | 19.51B | -5.52B | 25.30B | 31.21B | -10.63B | 17.74B |
| Net Income | 172.37B | 105.85B | 237.70B | 143.26B | 62.04B | 69.97B | 37.68B | 22.61B | 46.49B | 2.52B | -32.65B | 115.59B | 153.46B | 118.96B | 83.41B | -56.03B | 6.22B |
| Net Income Ratio | 5.37% | 3.19% | 7.65% | 5.80% | 2.49% | 2.73% | 1.57% | 0.98% | 2.14% | 0.11% | -1.40% | 6.20% | 13.00% | 11.18% | 4.48% | -4.09% | 0.52% |
| EPS | 22.27K | 13.68K | 30.71K | 18.51K | 8.02K | 9.04K | 4.87K | 2.92K | 6.01K | 329.00 | -4.37K | 19.28K | 18.57K | 16.90K | 16.32K | -10.97K | 1.24K |
| EPS Diluted | 22.27K | 13.68K | 30.71K | 18.51K | 8.02K | 9.04K | 4.87K | 2.92K | 6.01K | 329.00 | -4.37K | 19.28K | 18.57K | 6.19K | 16.32K | -10.97K | 1.24K |
| Weighted Avg Shares Out | 7.74M | 7.74M | 7.74M | 7.74M | 7.74M | 7.74M | 7.73M | 7.73M | 7.73M | 7.65M | 7.47M | 5.99M | 7.90M | 5.12M | 5.11M | 5.11M | 5.03M |
| Weighted Avg Shares Out (Dil) | 7.74M | 7.74M | 7.74M | 7.74M | 7.74M | 7.74M | 7.73M | 7.74M | 7.73M | 7.65M | 7.47M | 5.99M | 7.90M | 5.12M | 5.11M | 5.11M | 5.03M |
Source: https://incomestatements.info
Category: Stock Reports